YKL-40 as a novel diagnostic biomarker in Toxoplasmosis

被引:5
|
作者
Shahad, Farah Abd AL-Zahra [1 ]
Mohammed, Ahmed A. [1 ]
Jasim, Ghaith Ali [2 ]
机构
[1] Univ Mustansiriyah, Branch Clin Lab Sci, Coll Pharm, Baghdad, Iraq
[2] Univ Mustansiriyah, Branch Pharmacol & Toxicol, Coll Pharm, Baghdad, Iraq
关键词
biomarkers; diagnosis; Toxoplasma gondii; Toxoplasmosis; YKL-40; PREGNANT-WOMEN; GONDII; IMMUNITY; EPIDEMIOLOGY; PATHOGENESIS; IGM;
D O I
10.47750/jptcp.2022.932
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Toxoplasmosis is one of the most globally prevalent zoonotic infection caused by an obligate, intracellular parasite called Toxoplasma gondii. Toxoplasmosis actively triggers an acute immune response and inflammatory reactions, which causes serious pathological changes in various tissues in the human body, and more evidently localizes in different nervous tissues of various body organs. The YKL-40 is a glycoprotein secreted by numerous cell types in different patterns associated with various pathological processes such as inflammatory reactions, tissue remodeling, and fibrosis, and is a disease-specific biomarker of neuroinflammation. Therefore, this study aimed to determine whether the YKL-40 is markedly increased in toxoplasmosis or not and whether its level is different between the acute and chronic phases of the infection to determine if it can be used as a clinically useful biomarker in the diagnosis, and determination of disease severity and follow-up of toxoplasmosis. Accordingly, a total of 80 serum samples were collected from previously diagnosed female patients of different ages with toxoplasmosis. In addition, serum samples of 10 healthy females were used as the control. Patients were first divided into two groups (30 patients with acute infection, and 50 patients with chronic infection) depending on the results of detection of specific anti-Toxoplasma IgM and IgG by enzyme linked immunosorbent assay (ELISA). The level of YKL-40 was then measured in the patients' serum by ELISA. The statistical analysis of data clearly disclosed very highly significant differences (P < 0.001) between the level of YKL-40 in the acute infection group and healthy controls, chronic infection group and healthy controls, and between the groups with acute and chronic infections. These findings led to conclude that YKL-40 classify as a unique and sophisticated biomarker in the diagnosis of toxoplasmosis where it can vitally be used to detect the stage of the disease, whether acute or chronic, besides its ability to detect the infection.
引用
收藏
页码:E61 / E70
页数:10
相关论文
共 50 条
  • [41] YKL-40:: A novel serum marker for metastatic melanoma
    Lagares, Angel Diaz
    Gonzalez-Cao, Maria
    Gonzalez, Alvaro
    Viteri, Santiago
    de la Cruz, Susana
    Mugueta, Carmen
    Aramendia, Jose Manuel
    Algarra, Salvador Martin
    ANNALS OF ONCOLOGY, 2006, 17 : 164 - 165
  • [42] The diagnostic and prognostic value of serum YKL-40 in endometrial cancer
    Fan, Jiang-tao
    Si, Xiao-hui
    Liao, Yan
    Shen, Ping
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (01) : 111 - 115
  • [43] YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer's Disease
    Mavroudis, Ioannis
    Chowdhury, Rumana
    Petridis, Foivos
    Karantali, Eleni
    Chatzikonstantinou, Symela
    Balmus, Ioana Miruna
    Luca, Iuliana Simona
    Ciobica, Alin
    Kazis, Dimitrios
    MEDICINA-LITHUANIA, 2022, 58 (01):
  • [44] Elevated expression of YKL-40, a cancer biomarker, is associated with tumor angiogenesis
    Yan, Wei
    Cao, Jackie Qing
    Arenas, Richard B.
    Bentley, Brook
    Shao, Rong
    CANCER RESEARCH, 2010, 70
  • [45] YKL-40, a biomarker of inflammation, is not increased in patients with gestational diabetes mellitus
    Hoellerl, F.
    Brix, J. M.
    Placher-Sorko, G.
    Krzyzanowska, K.
    Schernthaner, G. H.
    Schernthaner, G.
    DIABETOLOGIA, 2009, 52 : S454 - S454
  • [46] The diagnostic and prognostic value of serum YKL-40 in endometrial cancer
    Jiang-tao Fan
    Xiao-hui Si
    Yan Liao
    Ping Shen
    Archives of Gynecology and Obstetrics, 2013, 287 : 111 - 115
  • [47] Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
    Erfan, Gamze
    Guzel, Savas
    Alpsoy, Seref
    Rifaioglu, Emine N.
    Kaya, Sule
    Kucukyalcin, Volkan
    Topcu, Birol
    Kulac, Mustafa
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 400 (1-2) : 207 - 212
  • [48] Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
    Gamze Erfan
    Savas Guzel
    Seref Alpsoy
    Emine N. Rifaioglu
    Sule Kaya
    Volkan Kucukyalcın
    Birol Topcu
    Mustafa Kulac
    Molecular and Cellular Biochemistry, 2015, 400 : 207 - 212
  • [49] Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
    Gao, Jing
    Laitinent, Tarja
    Iwamato, Hiroshi
    Mazur, Witold
    Pulkkinen, Ville
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [50] Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Tong, Xiang
    Wang, Dongguang
    Liu, Sitong
    Ma, Yao
    Fan, Hong
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (01)